Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

ROXYBOND 15 MG TABLET

Oxycodone hydrochloride
$18.1912per EA
High Outlier
DEA Schedule CII

Strength

15 mg/1

Manufacturer

Protega Pharmaceuticals Inc

NDC

81140010210

Classification

Brand

Dosage Form

TABLET, COATED

Route

ORAL

Last Updated

3/19/2025

Active Ingredients

OXYCODONE HYDROCHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA209777

On Market Since

4/20/2017

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

N/A

Generic Alternatives

Save up to 99%

1 alternative • Same active ingredient

OXYCODONE HCL (IR) 15 MG TAB
Generic
47781026401•Alvogen Inc.
$0.2087
Save 99%

Related Drugs

Same classification

HYCODAN 5 MG-1.5 MG/5 ML SOLN
Brand
64950034247•Genus Lifesciences Inc.
$0.0505
per ML
DILAUDID 5 MG/5 ML ORAL LIQUID
Brand
42858041616•Rhodes Pharmaceuticals L.P.
$0.8521
per ML
HYCODAN 5 MG-1.5 MG TABLET
Brand
64950020503•Genus Lifesciences Inc.
$1.0146
per EA
HYCODAN 5 MG-1.5 MG TABLET
Brand
64950020510•Genus Lifesciences Inc.
$1.0146
per EA
DILAUDID 4 MG TABLET
Brand
42858023401•Rhodes Pharmaceuticals L.P.
$3.9559
per EA
DILAUDID 4 MG TABLET
Brand
42858023450•Rhodes Pharmaceuticals L.P.
$3.9559
per EA
DEMEROL 50 MG/ML SYRINGE
Brand
00409117830•Hospira Inc.
$4.4738
per ML
MS CONTIN ER 15 MG TABLET
Brand
42858051501•Rhodes Pharmaceuticals L.P.
$4.6807
per EA
SUBOXONE 2 MG-0.5 MG SL FILM
Brand
12496120203•Indivior Inc.
$4.7853
per EA
ZUBSOLV 0.7-0.18 MG TABLET SL
Brand
54123090730•Orexo US, Inc.
$5.2599
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy